In vitro: FDA‑approved ivermectin inhibits SARS‑CoV‑2 replication

added blog Lifestyle

2025-06-20 11:33:22 -

The world was gripped by fear and confusion in early 2020 when the COVID-19 pandemic struck. In the race to find effective treatments, ivermectin, a well-known anti-parasitic drug, found itself at the center of a media storm. This frenzy stemmed from a laboratory (in vitro) study suggesting that ivermectin could inhibit the replication of SARS-CoV-2, the virus that causes COVID-19....

0 Comments 0 Shares 6 Views 0 Reviews